Ornit Chiba-Falek

Company: CLAIRIgene

Job title: Co-Founder

Seminars:

Preclinical Studies for Gene Therapies in Common NDDs: The Path From Human-Based Cellular Through Mouse Models 10:30 am

Neurodegenerative diseases (NDDs) in aging, on the spectrum of Alzheimer’s and Parkinson’s diseases, present unmet clinical need with no effective and safe disease modifying therapy (DMT) Gene-targeted therapies will move the field foward towards precision medicine Epigenome editing platform delivered by AAV offers the opportunity for the development of innovative therapeutics for NDDs caused by…Read more

day: Conference Day Two